|Venture Round, 9/07 |
Slater Technology Fund
Genome engages in developing and commercializing the DNA sequencing technology. It offers proprietary technologies, massively-parallel sanger sequencing, for sequencing and analyzing the genomes of individuals. The company serves researchers and clinicians. Genome Corp. was founded in 2007 and is based in Providence, Rhode Island.